Diet and cancer prevention: Dietary compounds, dietary MicroRNAs, and dietary exosomes by Banikazemi, Z. et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This article is protected by copyright. All rights reserved 
Prospects 
Diet and Cancer Prevention: Dietary Compounds, Dietary MicroRNAs and Dietary 
Exosomes
†
 
Zarrin Banikazemi 1, Hemat Aghagolzadeh Haji2, Mohsen Mohammadi3, Gholamreza 
Taheripak4, Elmira Iranifar5, Mohsen Poursadeghiyan6, Abdullah Moridikia7, Bahman 
Rashidi8, Mohsen Taghizadeh9, Hamed Mirzaei10 
1Biochemistry of Nutrition Research Center, School of Medicine, Mashhad University of 
Medical Science, Mashhad, Iran 
2 School of medicine, shahroud university of medical sciences, shahroud, Iran 
3Razi Herbal Medicines Research Center and Department of pharmaceutical biotechnology, 
Faculty of pharmacy, Lorestan University of Medical Sciences, Khorramabad, Iran 
 
4 Department of Biochemistry, Faculty of Medicine, Iran University of Medical Sciences, 
Tehran, Iran 
 
5 Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran 
6Research Center in Emergency and Disaster Health, University of Social Welfare and 
Rehabilitation Sciences, Tehran, Iran 
7Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, 
Iran 
8Department of Anatomical Sciences and Molecular Biology, School of Medicine, Isfahan 
University of Medical Sciences, Isfahan, Iran 
9Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University 
of Medical Sciences, Kashan, I.R. Iran 
10Department of Medical Biotechnology, School of Medicine, Mashhad University of 
Medical Sciences, Mashhad, Iran 
 
†This article has been accepted for publication and undergone full peer review but has not 
been through the copyediting, typesetting, pagination and proofreading process, which may 
lead to differences between this version and the Version of Record. Please cite this article as 
doi: [10.1002/jcb.26244] 
 
Received 1 June 2017; Revised 23 June 2017; Accepted 26 June 2017 
Journal of Cellular Biochemistry 
This article is protected by copyright. All rights reserved 
DOI 10.1002/jcb.26244 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This article is protected by copyright. All rights reserved 
 
Correspondence authors: 
Hamed Mirzaei. Department of Medical Biotechnology, School of Medicine, Mashhad 
University of Medical Sciences, Mashhad, Iran  ; Fax: +98 51 38002287; Tell: 0098 
9134226959; Email:   Mirzaeih911h@mums.ac.ir &  h.mirzei2002@gmail.com  
 
Mohsen Taghizadeh. Research Center for Biochemistry and Nutrition in Metabolic 
Diseases, Kashan University of Medical Sciences, Kashan, I.R. Iran 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This article is protected by copyright. All rights reserved 
Abstract  
Cancer is one of main health public problems worldwide. Several factors are involved in 
beginning and development of cancer. Genetic and internal/external environmental factors 
can be as important agents that effect on emerging and development of several cancers. Diet 
and nutrition may be as one of important factors in prevention or treatment of various 
cancers. A large number studies indicated that suitable dietary patterns may help to cancer 
prevention or could inhibit development of tumor in cancer patients. Moreover, a large 
numbers studies indicated that a variety of dietary compounds such as curcumin, green tea, 
folat, selenium and soy isoflavones show a wide range anti-cancer properties. It has been 
showed that these compounds via targeting a sequence of cellular and molecular pathways 
could be used as suitable options for cancer chemoprevention and cancer therapy. Recently, 
dietary microRNAs and exosomes have been emerged as attractive players in cancer 
prevention and cancer therapy. These molecules could change behavior of cancer cells via 
targeting various cellular and molecular pathways involved in cancer pathogenesis.  Hence, 
the utilization of dietary compounds which are associated with powerful molecules such as 
microRNAs and exosomes and put them in dietary patterns could contribute to prevention or 
treatment of various cancers.   Here, we summarized various studies that assessed effect of 
dietary patterns on cancer prevention shortly. Moreover, we highlighted the utilization of 
dietary compounds, dietary microRNAs and dietary exosomes and their cellular and 
molecular pathways in cancer chemoprevention. This article is protected by copyright. All 
rights reserved 
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Introduction  
Cancer is known as one of major public health problems which are associated with a public 
health concern worldwide (Ferlay et al., 2015). The assessing of different dimensions for this 
disease has led to identification of various factors involved in cancer pathogenesis. These 
findings could help to prevention and better treatment of various types of cancer (Mirzaei et 
al., 2016h; Mirzaei et al., 2016j). Various classes of factors participate in start and 
development of various cancers (Schottenfeld and Fraumeni Jr, 2006). Multiple lines 
evidences indicated that genetic and envirmental factors involved in various stages of 
different malignancies (Schottenfeld and Fraumeni Jr, 2006). To date, researchers with more 
understanding of molecular/cellular pathways involved in different cancers could design 
many therapies and regimen for before and after cancer. But, with growth of 
human knowledge in the cellular and molecular pathways involved in different stages of 
cancers, obtain new data that could contribute be design novel therapies (Mirzaei et al., 
2016d; Mirzaei et al., 2016h; Mirzaei et al., 2016j; Salarinia et al., 2016). Moreover, using of 
these data could lead to development of new therapies such as gene and cell therapy for 
treatment of cancer (Mirzaei et al., 2016d; Mirzaei et al., 2016f; Mohammadi et al., 2016b; 
Saadatpour et al., 2016b; Saadatpour et al., 2017). Among of various factors involved in start 
and development of cancer, life style has a main role. Human dietary patterns could effect on 
human health in various ways. The suitable nutrition regimen has important effects on human 
health (Couto et al., 2011). It observed that enough uptakes of various vitamins and fats could 
have positive effects on various diseases such as depression and cancer (Banikazemi et al., 
2016; Banikazemi et al., 2015; Chen et al., 2015b; Mayne et al., 2016). Various studies 
indicated that suitable diet and dietary patterns may have key roles in prevention or even 
treatment of cancer (Chen et al., 2015b; Rodriguez et al., 2004). The intake of various fruits 
and diet with many antioxidant components may help be prevention of cancer. The 
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inflammation is known as one of main factors for development of many cancers (Albanes et 
al., 1995; Catsburg et al., 2015; Marmot et al., 2007; Mayne et al., 2016; Rodriguez et al., 
2004). The utilization of suitable dietary including antioxidant components may effect on 
development of cancer and inhibition it (Albanes et al., 1995; Marmot et al., 2007; Mayne et 
al., 2016).  It’s found that a plant-based diet that limits red meat intake could  be linked with 
reduced risk of breast cancer (Catsburg et al., 2015).  
Dietary compounds are known as one of important therapeutic agents which could affect on a 
variety of cellular and molecular pathways (Chen and Kong, 2005; Langner and Rzeski, 
2012; Pan and Ho, 2008). A large number studies indicated that the utilization of various 
dietary compounds including green tea, curcumin, selenium, carotenoids and vitamins could 
help to cancer prevention and treatment. Hence, it seems that the utilization of them in dietary 
pattern could be useful for cancer prevention and therapy (Chen and Kong, 2005; Langner 
and Rzeski, 2012; Pan and Ho, 2008).  Recently, some studies indicated that dietary 
microRNAs and exosomes have critical roles in change behavior various cells such as cancer 
cells. MicroRNAs (miRNAs) are known as small non-coding RNAs which act as epigenetic 
regulators (Mirzaei et al., 2016a; Mirzaei et al., 2016g; Mohammadi et al., 2016a; Rashidi et 
al., 2016; Salarinia et al., 2016). These molecules have critical roles in a variety of cellular 
and molecular pathways involved in cancer pathogenesis (Gholamin et al., 2017; Mashreghi 
et al., 2017; Mirzaei et al., 2017a; Moridikia et al., 2017; Ross and Davis, 2014). Hence, 
these molecules could be used as diagnosis, and therapeutic biomarkers (Fathullahzadeh et 
al., 2016). It has been showed that dietary miRNAs could be as attractive tools for cancer 
prevention and therapy. Moreover, it has been showed that dietary exosomes and their cargos 
could be used as new candidate for cancer prevention and therapy (Ju et al., 2013; Mirzaei et 
al., 2017b; Record, 2013). Here, we summarized the role of dietary patterns on prevention of 
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cancer shortly. Moreover, we highlighted the utilization of dietary compounds, dietary 
miRNAs and dietary exosomes as powerful candidates for cancer prevention and therapy.   
Dietary patterns and cancer  
Multiple lines evidence indicated that many factors involve in different stages of cancer 
(Weiderpass, 2010). These factors (including genetic and envirmental factors) play key roles 
in start and development of different cancers (Kolonel et al., 2004; Mayne et al., 2016; 
Weiderpass, 2010).  Dietary patterns are probably known as one of important factors that may 
be associated with various cancers. Few studies have examined effect dietary patterns on 
cancer prevention (Chen et al., 2015b; Willett, 2000). Some evidences indicated that various 
dietary patterns cannot contribute to cancer prevention in different stages (Chen et al., 
2015b). On the other hand, some reports revealed that a healthy diet with plenty of vegetables 
and fruit may decrease risk of cancer. These studies indicated that the utilizing of suitable 
dietary patterns and particular vitamins may contribute to cancer prevention in certain groups 
of patients (Weinstein et al., 2007). In a study, Rodriguez  et al., found that intake of vitamin 
E supplements for male smokers could decrease risk of prostate cancer. Their results showed 
that supplementation with alpha-tocopherol (a form of vitamin E) can reduce risk of prostate 
cancer (Rodriguez et al., 2004).  In four studies observed that  vitamin E could decrease the 
risk of prostate cancer in past/recent and current smokers and those with low levels of this 
vitamin (Moyad, 2002; Weinstein et al., 2007). Moyad et al., found that selenium and vitamin 
E are probably 2 of the main dietary supplements which  utilization of them could decrease 
prostate cancer risk (Moyad, 2002).  Some reports revealed that there were no significant 
reduction between multivitamin, mineral supplementation and mortality or incidence of 
cancer, while some reports show a possible prevention effect in cervical cancer (Dolara et al., 
2012). In 2012 a review of 9 studies assessed the effect of various vitamins and minerals on 
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lung cancer risk. Their results showed that there was no evidence for recommending 
supplements of vitamins A, C, E, selenium, either alone or in different combinations, for the 
prevention of lung cancer and lung cancer mortality in healthy people. Moreover, some 
evidence indicated that the use of beta-carotene supplements could be related with a small 
increase in lung cancer incidence and mortality in smokers or persons exposed to 
asbestos.(Cortes-Jofre et al., 2012) . Finally, there are no strong evidences that dietary 
supplements and dietary patterns can contribute to prevention, control and treat various 
cancers. But few small pilot studies have found that nutritional supplements and dietary 
patterns may contribute to prevention, treat and control of cancer for some subjects (Béliveau 
and Gingras, 2007; Chen et al., 2015b; Dolara et al., 2012). Hence, choosing suitable dietary 
supplements can help to prevention of cancer and effective treatment during cancer. It seems 
that examining of various dietary patterns on cancer patients can be contribute to identifying 
of new dietary patterns that are effective on the prevention, treatment and control of various 
cancers.  
Dietary compounds and cancer chemoprevention 
Cancer chemoprevention is known as an approach which employed natural or synthetic 
agents to decrease or suppress cancer development and progression (Chen and Kong, 2005; 
Langner and Rzeski, 2012; Pan and Ho, 2008). It has been showed that dietary compounds 
could be used as a suitable therapeutic agent for cancer chemoprevention. The interesting of 
utilization of dietary compounds due to specific properties of them such as low toxicity 
compared with regular drugs. Multiple lines evidence indicated that a wide range of dietary 
chemo-preventive agents such as long-chain polyunsaturated fatty acids, green tea 
polyphenols (i.e. catechins), carotenoids, curcumin, vitamins (i.e. vitamin D and folate) 
glucosinolates/isothiocyanates, and minerals (i.e. calcium and selenium) could be introduced 
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into clinical application for cancer therapy  (Chen and Kong, 2005; Langner and Rzeski, 
2012; Pan and Ho, 2008) (Table 1) . 
Curcumin is one of interesting phytochemicals which shows wide ranges anti-cancer 
properties (Mirzaei et al., 2016b; Mirzaei et al., 2016c; Mirzaei et al., 2017d). Several studies 
indicated that curcumin via targeting a sequence cellular and molecular pathways exert its 
therapeutic effects (Mirzaei et al., 2016b; Mirzaei et al., 2016c; Mirzaei et al., 2017d). A 
variety of cellular and molecular targets including microRNAs (miRNAs), NF-κB, AP-1, 
COX-2, MMPs, cyclin D1, EGFR, Akt, β-catenin, adhesion molecules and TNF could be 
affected by curcumin (Mirzaei et al., 2016b; Mirzaei et al., 2016c; Mirzaei et al., 2017d; 
Simonian et al., 2017) (Figure 1).  
Green tea is other natural components which is associated with wide ranges of therapeutic 
properties (Rashidi et al., 2017). It has been showed that this plant is a rich source of proteins 
(including enzymes), amino acids, carbohydrates, lipids, vitamins (B, C, E) and minerals (i.e. 
Ca, Mg, Cr, Fe, Zn, F, K) (McKay and Blumberg, 2002). Various studies indicated that is 
mostly therapeutic effects of Green tea is related with the abundance of polyphenols, 
particularly flavonoids. Catechins (flavan-3-ols) including including epicatechin (EC), 
epicatechin-3-gallate (ECG), gallocatechin (GC), epigallocatechin (EGC) and predominant (-
)-epigallocatechin-3-gallate (EGCG) are one of important flavonoids present in green tea 
leaves (Langner and Rzeski, 2012). It has been that Green tea exerts its anti-cancer properties 
via inhibition of growth tumor via targeting cellular and molecular involved in cell 
proliferation, and angiogenesis. VEGFs are one of important targets which could be affected 
by this component (Rashidi et al., 2017).  
Epigenetic mechanisms are important pathways which could be affected by dietary 
compounds in cancer chemoprevention (Hardy and Tollefsbol, 2011; Li et al., 2014). There 
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are different mechanisms including DNA methylation, histone modifications, and 
microRNAs (miRNAs) which act as epigenetic regulators (Mirzaei et al., 2016g; Salarinia et 
al., 2016). It has been indicated that dietary compounds could affect on cancer prevention via 
targeting of epigenetic mechanisms (Hardy and Tollefsbol, 2011; Li et al., 2014).  A large 
number studies revealed that bioactive phytochemicals are able to change expression of a 
variety of oncogens and tumor suppressor genes via targeting epigenetic mechanisms 
involved in cancer initiation and progression (Hardy and Tollefsbol, 2011; Li et al., 2014). 
Moreover, the utilization of bioactive phytochemicals alone or in combination with other 
natural or synthetic agents could be associated with significant results against a variety of 
cancers (Hardy and Tollefsbol, 2011; Li et al., 2014).  
Finally, it seems that the utilization of dietary compounds and put them in dietary patterns 
could be associated with significant results against prevention of a variety of cancers. Hence, 
we offer that the utilization of them could be employed as powerful candidates in dietary 
patterns which may contribute to new insights into cancer prevention. 
Dietary microRNA and cancer prevention  
 MicroRNA (miRNA) is small noncoding RNAs which acts as epigenetic negative/positive 
regulators in various physiological processes (Gholamin et al., 2016; Goradel et al., 2017; 
Hashemi Goradel et al., 2017; Mirzaei, 2017; Simonian et al., 2017). These molecules could 
act as a tumor suppressor or oncogene (Keshavarzi et al., 2017a; Rabieian et al., 2017). It has 
been showed that these molecules are able to regulate a wide range of cellular and molecular 
processes such as growth, angiogenesis, cell death, invasive and metastasis (Gholamin et al., 
2017; Mirzaei et al., 2016i). Multiple line evidence indicated that deregulation of them could 
lead to disease condition (Hoseini et al., 2017; Keshavarzi et al., 2017b; Mirzaei et al., 
2017c). A variety of miRNAs could affect on initiation and development.t of various types of 
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cancer. Hence, identification of them could contribute to better understanding of underlying 
cellular and molecular pathways and could lead to better treatment for patients with various 
diseases such as cancer.  It has been showed that a variety of dietary compounds and 
bioactive foods could show inhibitory effects on cancer cells and also protective effects 
against cancer via modulating a variety of miRNAs involved in cancer pathogenesis (Nolte-'t 
Hoen et al., 2015; Ross and Davis, 2011; Ross and Davis, 2014). A large number studies 
indicated that dietary compounds and bioactive foods could change expression of various 
miRNAs involved in various well known cancer processes such as angiogenesis, cell cycle 
regulation, apoptosis, differentiation, inflammation, metastasis and pathways involved in  
stress response (Cui et al., 2017; Neelakandan et al., 2012; Parasramka et al., 2012; Ross and 
Davis, 2011). Hence, understanding the affect of dietary compounds and bioactive foods on 
miRNA expression and miRNA function could provide new insight on prevention approaches 
to decrease the burden of cancer. 
Many studies assessed effect of essential nutrients, and phytochemicals on regulation of 
miRNA expression in various types of cancer cells and other model systems. Few studies 
investigated the role of various dietary patterns (i.e. Western diet) or alterations in 
macronutrient content (i.e. caloric restriction) on expression of miRNAs and miRNA function 
(Zhu et al., 2011).  
EGFR signals such as MYC and K-Ras are important signaling pathways which are 
associated with modulating of a variety miRNAs such as miR-143 and miR-145 in cancer 
tumorgensis (Dougherty et al., 2009; Zhu et al., 2011). It has been showed that Western diet 
(known as a diet with high levels of animal fat and low levels of cholecalciferol and calcium) 
could induce colonic tumorigenesis via targeting EGFR signals (Newmark et al., 2001). It has 
been showed that Western diet via targeting EGFR could suppress miR-143 and miR-145 
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(known as tumor suppressor genes) which led to increasing colonic tumorigenesis and up-
regulation of  miRNA targets such as MYC and K-Ras (Zhu et al., 2011). 
It has been showed that Dietary folate could be associated with regulation of miRNA 
expression in different model systems and this could be related to the activity of folate in 
cancer prevention and risk. In a study, Marsit et al., indicated that deficiency of folate in 
growth media of human lymphoblastoid cells could induce significant changes expression 
levels of  24 miRNA such as miR-222 (Marsit et al., 2006). They showed that when folate 
was added back to the media,expression profiles of miRNAs  returned to that of control cells. 
These findings suggested that folate and some dietary components could modulate expression 
of various miRNAs and deregulation of these miRNAs might be suitable biomarkers of 
nutritional status in humans as well as participants in cancer prevention (Marsit et al., 2006).  
Vitamin E is other dietary components which could regulate miRNA expression. In a study, 
Gaedicke et al., indicated that  utilization of diet with vitamin E deficiency (α tocopherol, < 1 
mg/kg diet; γ tocopherol, < 1 mg/kg diet) for 6 month than a vitamin E-sufficient diet (α 
tocopherol, 12 mg/kg diet; γ tocopherol, 24 mg/kg diet) could change miRNA expression in a 
rat model (Gaedicke et al., 2008). They showed that vitamin E deficiency could lead to 
decreasing of hepatic miR-122a and miR-125b expression. These miRNAs could be involved 
in lipid metabolism, inflammation, and HCC. These results suggested that providing of a 
dietary regimen with appropriate vitamin E status could exert its prevention regulatory 
properties via regulating miRNA expression which involved in cancer prevention (Gaedicke 
et al., 2008).  
MiR-21 is one of important targets of curcumin which could be involved in a wide range of 
cancer associated pathways (Chen et al., 2015a). Deregulation of miR-21 is associated with 
initiation and progression of various cancers. It has been showed that curcumin exerts anti-
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This article is protected by copyright. All rights reserved 
cancer properties via down regulation of miR-2 in various types of cancer.  It has been 
showed that miR-21 acts as one of important players in a variety of cancer associated 
processes such as proliferation, apoptosis, metastasis and drug resistance (Melnik, 2015; 
Mudduluru et al., 2011; Roy et al., 2013; Yang et al., 2013). A large number studies 
confirmed that miR-21 exerts its pathological effects via affecting various downstream 
pathways including phosphatase and tensin homolog (PTEN)/phosphoinositide 3-
kinase/protein kinase B (PI3K/Akt), programmed cell death protein 4 (PDCD4) and NF-κB 
pathways (Melnik, 2015). Moreover, It has been showed that curcumin could affect on 
various cancers via affecting on exosomes containing miR-21 which has critical roles in 
progression of cancer (Wang et al., 2017a). Hence, miR-21 is one of major targets of 
curcumin which curcumin and its analogs exert their therapeutic effect via modulating of it. 
Multiple lines evidence indicated that dietary factors may have adverse effects on microRNA 
signaling and could induce various types tumor (Melnik, 2015). For example, some studies 
indicated that there are significant relation between melanoma incidence and BMI (Calo et 
al., 2016; Candido et al., 2014). Among of various cellular and molecular targets which 
involved in BMI, MiR-21 is one of important players in this area. It has been showed that 
miR-21 could be involved in adipocyte differentiation and up regulation of it could be 
associated with obesity in obese subjects (Chartoumpekis et al., 2012; Kang et al., 2013; 
Keller et al., 2011). In the other hand, inhibition of miR-21 could be associated with 
reduction of obesity in db/db mice (Seeger et al., 2014). In a study, Pandey et al., indicated 
that HFD-induced obesity could be related with increasing of melanoma progression via 
targeting Cav-1 and FASN expression in tumors from HFD mice (Pandey et al., 2012). 
Moreover, adipocytes could release exosomes containing various miRNAs which could affect 
on various pathways (Ferrante et al., 2015; Muller et al., 2011).   These findings suggested 
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that dietary miRNAs and dietary exosomes containing miRNAs may have critical roles in 
progression of various types of cancer.  
 
 
Dietary effects on exosomal microRNAs and their role in cancer prevention 
Exosomes are known as nano vesicles with 50–100 nm in diameter. Exosomes consist of a 
lipid bilayer membrane and a variety of proteins (Wagner et al., 2015). Moreover, it has been 
showed that these nano-criers could carry a variety of molecules such as DNAs, small non-
coding RNAs( i.e. microRNAs) and various proteins(Mirzaei et al., 2016e; Saadatpour et al., 
2016a).  It has been showed that exosomes play critical roles in cell-to-cell communication. 
These vehicles via targeting their cargos could change behaviors recipient cells. Multiple 
lines evidence indicated that exosomes have important roles in initation and progression of a 
variety of diseases such as cancer (Mirzaei et al., 2016e; Saadatpour et al., 2016a). These 
vehicles via targeting their cargos to recipient cells could lead to activation/inhibition of a 
sequence of cellular and molecular pathways involved in cancer (Mirzaei et al., 2016e; 
Saadatpour et al., 2016a).  Recently, few studies indicated that dietary exosomes could be 
used as effective tools for cancer therapy. In a study, Ju et al., indicated that grape exosome-
like nanoparticles (GELNs) could induce intestinal stem cells and protect mice from DSS-
induced colitis (Ju et al., 2013). They results indicated that GELNs are able to travel within 
the gut and migrate through the intestinal mucus. They could be taken up by mouse intestinal 
stem cells and could induce the proliferation of intestinal stem cells. These finding suggested 
that edible exosomes could be used as effective candidates for prevention and treatment of a 
variety of diseases (Ju et al., 2013).  
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One of important exosomes cargos are miRNAs. It has been showed that a variety of dietary 
components are able to modulate expression of miRNAs in various models (Wagner et al., 
2015). These regulations could lead to decreasing of cancer risk. Hence, it seems that dietary 
exosomes via introducing various cargos such as miRNAs could exert their therapeutic. It 
seems that future studies could open new windows in this area.  
It has been showed that only viable cells are able to synthesize and release exosomes that 
could carry miRNAs to recipient cells. Dietary factors with nutrigenomic effects may modify 
the miRNA composition and content of cell-derived exosomes (Cui et al., 2017; Neelakandan 
et al., 2012; Parasramka et al., 2012).  
Recent efforts have been undertaken to use milk-derived exosomes foe the encapsulation 
curcumin which could enhance curcumin transport and drug effects. These results suggested 
that using milk-derived exosomes containing curcumin could induce therapeutic effects of 
curcumin in the better way than using curcumin alone (Vashisht et al., 2017).  
Dietary exosomes and cancer promotion 
Various types of cells such as Somatic cells, immune cells, tumor cells, and mammary gland 
epithelial cells especially during lactation could release abundant exosomes for mRNA-, 
protein- and miRNA-mediated cell-cell communication, which has favorable (breastfed 
infant) or adverse effects on human health (Melnik, 2015). Numerous studies indicated that 
bovine milk could provide various bioactive exosomal miRNAs (Reinhardt et al., 2012; Sun 
et al., 2013). MiR-29b is one of exosomal miRNAs which could be absorbed by humans in 
biologically meaningful amounts. The uptake of this could be associated with increasing its 
systemic circulation and leads to alteration of gene expression of the milk consumer (Baier et 
al., 2014; Melnik et al., 2013).  It has been showed that almost 245 miRNAs could be 
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presented in cow’s milk. These miRNAs could affect on 11,000 human genes in the human 
(Baier et al., 2014). Hence, Milk could be suggested as an epigenetic transfection system that 
could promote postnatal growth via transferring a variety of miRNAs involved in various 
cellular and molecular pathways (Melnik et al., 2013). Moreover, bovine miRNAs of cow’s 
milk could be survived in various processing such as pasteurization, homogenization and 
refrigerated storage for over 2 weeks (Howard et al., 2015).  
Exosomal miR-21 is one of major miRNAs present in cow’s milk (Chen et al., 2010; Sun et 
al., 2013). It has been showed that increasing of milk consumption could be associated with 
progression of hepatocellular carcinoma (Duarte-Salles et al., 2014). It has been showed that 
interleukin 6 (IL-6) is able to induces STAT3-dependent miR-21 transcription in 
hepatocellular carcinoma (Loffler et al., 2007). In a study, Michaëlsson et al., indicated that 
there are a positive correlation between milk intake and high levels of IL-6 (Michaelsson et 
al., 2014). The increasing of serum IL-6 levels has been related with a worse prognosis of 
melanoma (Hoejberg et al., 2012; von Felbert et al., 2005). Milk exosomal miR-155 is other 
important molecules which could be inovolved in STAT3-mediated tumorigenesis (Cao et al., 
2013). It has been showed that miR-155 could induce STAT3 expression via inhibition of 
cytokine signaling 1 (SOCS1) which is known as a target of miR-155 (Cao et al., 2013; Zhao 
et al., 2013). Up regulation of miR-21 and miR-155 could be related with progression of 
melanocytic lesions. Exosomal TGFβ is other proteins which could be transmited by 
commercial milk (Pieters et al., 2015). It has been showed that TGFβ signaling induces up 
regulation of miR-21 via stimulating the processing of primary transcripts of miR-21 (pri-
miR-21) into precursor miR-21 (pre-miR-21) by the DROSHA complex (Davis et al., 2008). 
Hence, milk exosomes could be associated with progression of cancer via targeting various 
miRNAs and proteins such as miR-21, miR-155 and TGFβ.  
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Conclusion  
Dietary patterns are known as one of main risk factors for various cancers. It has observed 
that various dietary patterns such as meat (red meat, processed meat, fish and processed fish) 
or sugary-diet pattern are associated with risk of various cancers.  In addition, multiple lines 
evidences indicated that plant dietary patterns have many antioxidant and anti-inflammatory 
components such as vitamin E that may be suitable for prevention or treatment of various 
cancers. The effect of various dietary patterns for prevention or treatments of different cancer 
remains unclear yet. Hence, more studies for showing positive or negative roles of them in 
cancer prevention are still required to be done. Moreover, a large numbers studies indicated 
that dietary compounds, dietary microRNAs and dietary exosomes could have critical roles in 
cancer prevention and therapy. Dietary compounds including curcumin, greet tea 
components, carotenoids, minerals and vitamins could affect on a variety of cellular and 
molecular targets which are involved in cancer initiation and progression. Hence, it seems 
that the applying of them in various dietary patterns could be useful for cancer prevention and 
therapy.   
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Table 1. A variety of dietary compounds which are associated with anti-cancer properties 
Dietary compound (s) Cancer Target gene (s) Effect (s) Citation  
Green tea  Bladder 
PI3K/Akt, Bcl-
2 family 
 
The enhancing 
of  apoptosis  
(Qin et al., 
2007) 
Glioblastoma  
MMP-2 
, MT1-MMP 
 
Inhibition of 
tumor growth 
(Annabi et 
al., 2002) 
Breast  VEGF Inhibition of 
angiogenesis  
(Sartippour 
et al., 
2002) 
Polyunsaturated fatty acids 
 
Colon  COX-1 or 
COX- 
Inhibition of 
tumor growth 
(Boudreau 
et al., 
2001) 
Breast  - Inhibition of 
tumor growth 
(Bartsch et 
al., 1999) 
Prostate  - Inhibition of 
tumor growth 
(Rose and 
Cohen, 
1988) 
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Glucosinolates/isothiocyanates 
 
Lung  - Inhibition of 
growth tumor  
(Kvåle et 
al., 1983) 
Stomach  - Inhibition of 
growth tumor 
(Chyou et 
al., 1990) 
Colon  - Inhibition of 
growth tumor 
(Steinmetz 
et al., 
1994) 
Prostate  - Inhibition of 
growth tumor 
(Hsing et 
al., 1990) 
Carotenoids 
 
Colon  
cyclin D1, Bcl-
2 and Bcl-xL 
 
Induce 
apoptosis and 
inhibition of 
tumor growth 
(Palozza et 
al., 2007) 
Prostate  AKT, cyclin 
D1 
inhibition of 
tumor growth 
(Ivanov et 
al., 2007) 
Breast  RARalpha and 
Cx43 
inhibition of 
tumor growth 
(Chalabi et 
al., 2007) 
Vitamin D  
Colon  p21, MIB-1 inhibition of 
tumor growth 
(Fedirko et 
al., 2009; 
Lamprecht 
and 
Lipkin, 
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2001) 
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Folate 
 
Colon  COX2 inhibition of 
tumor growth 
(Vaisman 
and Arber, 
2002) 
Selenium 
 
Leukemia  cyclin B1 Inhibition of 
cell 
proliferation  
(Fimognari 
et al., 
2004) 
Calcium 
 
Colon  COX2 inhibition of 
tumor growth 
(Vaisman 
and Arber, 
2002) 
Curcumin  
Melanoma  
COX-2 
 
Inhibition of 
cell 
proliferation 
(Niu et al., 
2016; 
Pisano et 
al., 2016) 
Colon  - Inducing 
apoptosis , 
ROS, and  ER 
stress 
(Zhang et 
al., 2017) 
Glioblastoma  - Inducing 
apoptosis 
(Wang et 
al., 2017) 
Gastric  p53, Bcl-2, Bax 
and c-Myc 
Inhibition of 
cell 
proliferation, 
(Liu et al., 
2016) 
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Inducing 
apoptosis 
Breast  miR-29b-1-5p, 
PPARG, 
RRM2, 
SRSF1and 
EPAS1 
Inhibition of 
tumor growth 
(Tajbakhsh 
et al., 
2017; 
Zhou et al., 
2017) 
Head and 
neck  
 Inhibition of 
tumor growth 
(Basak et 
al., 2015) 
Lung  miR-30c 
Increasing the 
sensitivity of 
Paclitaxel-
resistant  
, Inhibition of 
tumor growth 
(Lu et al., 
2017) 
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Table 2. Dietary microRNA involved in cancer prevention  
Dietary 
component 
Cell line   MicroRNA    Expression in 
cancer 
Citation  
Folate TK-6 miR-222 Up regulation  (Marsit et al., 
2006) 
RA NB4 miR-15a  Up regulation (Garzon et 
al., 2007) 
miR-15b  Up regulation (Garzon et 
al., 2007) 
miR-16–1 Up regulation (Garzon et 
al., 2007) 
let-7a-3  Up regulation (Garzon et 
al., 2007) 
let-7c Up regulation (Garzon et 
al., 2007) 
let-7d  Up regulation (Garzon et 
al., 2007) 
miR-223  Up regulation (Garzon et 
al., 2007) 
miR-342  Up regulation (Garzon et 
al., 2007) 
miR-107 Up regulation (Garzon et 
al., 2007) 
miR-181b Down (Garzon et 
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regulation  al., 2007) 
RA SK-N-BE, 
LAN5 and 
SHSY-5Y 
miR-10a  Up regulation (Foley et al., 
2011) 
miR-10b Up regulation (Foley et al., 
2011) 
1,25(OH)2D HL60 and 
U937 
miR181a  Down 
regulation  
(Wang et al., 
2009) 
miR181b Down 
regulation  
(Wang et al., 
2009) 
1,25(OH)2D MCF12F miR-26b  Down 
regulation 
(Peng et al., 
2010) 
miR-200c Down 
regulation 
(Peng et al., 
2010) 
miR-200b  Down 
regulation 
(Peng et al., 
2010) 
miR-182 Down 
regulation 
(Peng et al., 
2010) 
Let-7b Up regulation (Peng et al., 
2010) 
Sodium 
selenite 
LNCaP miR-34b  Up regulation (Sarveswaran 
et al., 2010) 
miR-34c Up regulation (Sarveswaran 
et al., 2010) 
EGCG HepG2 miR-18a  Down 
regulation 
(Tsang and 
Kwok, 2010) 
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miR-34b Down 
regulation 
(Tsang and 
Kwok, 2010) 
miR-193b Down 
regulation 
(Tsang and 
Kwok, 2010) 
miR-222  Down 
regulation 
(Tsang and 
Kwok, 2010) 
miR-342 Down 
regulation 
(Tsang and 
Kwok, 2010) 
let-7a,  Up regulation (Tsang and 
Kwok, 2010) 
miR-16  Up regulation (Tsang and 
Kwok, 2010) 
miR-221 Up regulation (Tsang and 
Kwok, 2010) 
Curcumin BxPC-3 miR-22 Up regulation (Sun et al., 
2008) 
miR-199a Down 
regulation 
(Sun et al., 
2008) 
Curcumin  MCF-7 miR-15a  Up regulation  (Yang et al., 
2010) 
miR-16 Up regulation (Yang et al., 
2010) 
DIM MiaPaCa-2, 
Panc-1 and 
L3.6pl 
miR-200b  Up regulation (Li et al., 
2009) 
miR-200c  Up regulation (Li et al., 
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2009) 
let-7b Up regulation (Li et al., 
2009) 
let-7e Up regulation (Li et al., 
2009) 
Isoflavones MiaPaCa-2, 
Panc-1 and 
L3.6pl 
miR-200b  Up regulation (Li et al., 
2009) 
miR-200c  Up regulation (Li et al., 
2009) 
let-7b Up regulation (Li et al., 
2009) 
let-7e Up regulation (Li et al., 
2009) 
Genistein PC-3 miR-221  Down 
regulation 
(Chen et al., 
2011) 
miR-222 Down 
regulation 
(Chen et al., 
2011) 
Resveratrol LNCaP miR-150  Up regulation (Dhar et al., 
2011) 
miR-296–5p Up regulation (Dhar et al., 
2011) 
miR-7 Down 
regulation 
(Dhar et al., 
2011) 
miR-17  Down 
regulation 
(Dhar et al., 
2011) 
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miR-20a Down 
regulation 
(Dhar et al., 
2011) 
miR-18b Down 
regulation 
(Dhar et al., 
2011) 
miR-20b  Down 
regulation 
(Dhar et al., 
2011) 
miR-92b  Down 
regulation 
(Dhar et al., 
2011) 
miR-106a  Down 
regulation 
(Dhar et al., 
2011) 
miR106b Down 
regulation 
(Dhar et al., 
2011) 
SCFA 
butyrate 
HCT-116 miR-17 Down 
regulation 
(Hu et al., 
2011) 
miR-20a Down 
regulation 
(Hu et al., 
2011) 
miR-20b  Down 
regulation 
(Hu et al., 
2011) 
miR-93 Down 
regulation 
(Hu et al., 
2011) 
miR-106a  Down 
regulation 
(Hu et al., 
2011) 
miR-106b Down 
regulation 
(Hu et al., 
2011) 
Oleic acid HepG2 miR-21 Up regulation (Vinciguerra 
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et al., 2009) 
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Figure 1. Various cellular and molecular targets which regulated by curcumin and its analogs 
 
